Félags- og heilbrigðismál - 01.07.2003, Qupperneq 111

Heilbrigðismál
109
Tafla 6.3.15. Neysla og söluverðmæti lyfja eftir aðalverkunarflokkum lyfja á Norðurlöndum 2000
Table 6.3.15. Consumption and sales value of medicinal products by main therapeutic groups, in the Nordic countries 2000
Danmörk Finnland Island Noregur Svíþjóð
Denmark Finland Iceland Norway Sweden
DDD á 1.000 íbúa á dag Neysla/sala alls1 942 1.110 967 1.036 1.210 DDI) per 1,000 inhabitants a day Consumption/sale, total'
A Meltingarfæralyf 122 145 88 145 201 Alimentary tract and metabolism
B Blóðlyf 65 109 25 89 108 Blood and bloodforming organs
C Hjarta- og æðalyf 246 290 235 276 289 Cardiovascular system
G Þvagfæralyf, kvensjúkd.lyf og kynhormónar 107 130 155 105 132 Genito-urin. system and sex horm.
H Hormónalyf, önnur en kynhormón 24 31 26 33 35 Systemic horm. prep. excl. sex horm.
J Sýkingalyf 15 24 21 17 18 General antiinfectives, systemic
L Krabbameinslyf 4 4 4 5 6 Antineoplastic and immunomodulating agents
M Vöðva- og beinalyf 38 74 58 43 51 Musculo-skeletal system
N Tauga- og geðlyf 209 176 243 162 218 Central nervous system
P Sníklalyf 2 1 2 1 1 Antiparasitica
R Öndunarfæralyf 104 112 101 145 136 Respiratory system
S Augn- og eymalyf 8 12 10 15 16 Sensory organs
V Ýmislyf - - - - - Miscellaneous
Söluverðmæti, í milljónum evra2 Alls 1.515,1 1.615,0 132,3 1.480,0 2.765,3 Sales value, mill. euros2 Total
A Meltingarfæralyf 169,3 188,0 15,1 181,0 440,3 Alimentary tract and metabolism
B Blóðlyf 87,5 70,0 6,4 72,0 216,2 Blood and bloodforming organs
C Hjarta- og æðalyf 215,6 311,0 16,2 305,0 399,5 Cardiovascular system
D Húðlyf 44,1 53,0 4,4 41,0 93,0 Dermatologicals
G Þvagfæralyf, kvensjúkd.lyf og kynhormónar 90,2 120,0 9,5 77,0 170,6 Genito-urin. system and sex horm.
H Hormónalyf, önnur en kynhormón 27,4 34,0 2,6 36,0 79,3 Systemic horm. prep. excl. sex horm.
J Sýkingalyf 130,8 132,0 11,2 83,0 198,9 General antiinfectives, systemic
L Krabbameinslyf 64,1 87,0 5,7 81,0 178,7 Antineoplastic and immunomodulating agents
M Vöðva- og beinalyf 56,7 122,0 6,8 66,0 114,7 Musculo-skeletal system
N Tauga- og geðlyf 402,9 282,0 37,3 298,0 546,9 Central nervous system
P Sníklalyf 8,9 5,0 0,5 4,0 7,4 Antiparasitica
R Öndunarfæralyf 171,7 165,0 12,1 179,0 228,6 Respiratory system
S Augn- og eymalyf 29,1 32,0 2,6 36,0 54,5 Sensory organs
V Ýmislyf 16,2 15,0 1,7 21,0 36,4 Miscellaneous
Söluvcrðmæti í evrum á íbúa2 Alls 284 312 471 330 312 Sales value, euros per capitu2 Total
A Meltingarfæralyf 32 36 54 40 50 Alimentary tract and metabolism
B Blóðlyf 16 14 23 16 24 Blood and bloodforming organs
C Hjarta- og æðalyf 40 60 58 68 45 Cardiovascular system
D Húðlyf 8 10 16 9 10 Dermatologicals
G Þvagfæralyf, kvensjúkd.lyf og kynhormónar 17 23 34 17 19 Genito-urin. system and sex horm.
H Hormónalyf, önnur en kynhormón 5 7 9 8 9 Systemic horm. prep. excl. sex horm.
J Sýkingalyf 25 26 40 18 22 General antiinfectives, systemic
L Krabbameinslyf 12 17 20 18 20 Antineoplastic and immunomodulating agents
M Vöðva- og beinalyf 11 24 24 15 13 Musculo-skeletal system
N Tauga- og geðlyf 75 54 133 66 62 Central nervous system
P Sníklalyf 2 1 2 1 1 Antiparasitica
R Öndunarfæralyf 32 32 43 40 26 Respiratory system
S Augn- og eymalyf 5 6 9 8 6 Sensory organs
V Ýmislyf 3 3 6 5 4 MisceUaneous
1 Sala á B05 og D er ekki meðtalin hér vegna mismunandi skilgreininga á DDD í löndunum. A11 er ekki meðtalið vegna mismunandi skilgreininga á lyfjavörum
og heilsuvörum. Sales ofB05 andDare excludedfrom this table because of differences in the use ofnational DDDs. All is excluded because of differrences
in the definitions of medicinal and non-medicinal products.
2 Söluverðmæti lyfja er hér reiknað á apóteksverði með virðisaukaskatti. Sales value is calculated at pharmacy retail prices.
Heimild Source: NOMESKO (Health Statistics in the Nordic Countries 2000), Hagstofa íslands. NOMESCO (Health Statistics in the Nordic Countries 2000),
Statistics Iceland.